2020-CL-0102 (Evolve) - Clinical Trial

¿Cuál es el Propósito de este estudio?

This study is a research study that watches how a vision problem changes over time. The condition is called Stargardt disease or Stargardt type macular dystrophy, which affects how well a person can see. Researchers will follow people with this condition and collect information to learn how vision changes. The goal is to better understand the disease so doctors can improve care and treatment in the future.

¿Cuál es la Condición que se está estudiando?

Stargardt or Stargardt-type macular dystrophy

¿Quién puede participar en el Estudio?

People can join this study if they are 18 years old or older and have been diagnosed with a vision disease called Stargardt disease or a similar condition that affects the back of the eye. They cannot join if they have uncontrolled glaucoma, which is a serious eye disease that can damage vision.

Grupo etario
Adultos

¿Qué Implica?

This study is a research study that watches how a vision problem changes over time. The condition is called Stargardt disease or Stargardt type macular dystrophy, which affects how well a person can see. Researchers will follow people with this condition and collect information to learn how vision changes. The goal is to better understand the disease so doctors can improve care and treatment in the future.

Detalles del Estudio

Título Completo
An Observational Study of Natural Disease Progression in Participants with Macular Dystrophies Expressing a Stargardt-type Clinical Presentation - (Evolve)
Investigador Principal
Oleg Alekseev, MD, PhD
Especialista en oftalmología
Número de Protocolo
IRB: PRO00119889
NCT: NCT07425574
Fase
Fase N/A
ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health